Skip to main content

Retail Clinics

  • Allergy season to last longer this year

    JACKSONVILLE, Fla. — The 2011 allergy season is expected to be 27 days longer in the northernmost parts of North America, adding almost a month of suffering to the typical pollen allergy season of February through October, a study published Tuesday by the Proceedings of the National Academy of Sciences determined.

  • HHS seeks to reduce health disparities

    WASHINGTON — The Department of Health and Human Services on Friday launched two plans aimed at reducing health disparities.

    “For the first time, the United States has a coordinated road map designed to give everyone the chance to live a healthy life,” stated HHS secretary Kathleen Sebelius. “We all need to work together to combat this persistent problem so that we can build healthier communities and a stronger nation.”

  • Hi-Tech granted tentative approval for generic Levaquin

    AMITYVILLE, N.Y. — The Food and Drug Administration has granted tentative approval to a generic antibiotic made by Hi-Tech Pharmacal, the drug maker said Friday.

    Hi-Tech announced the tentative approval of levofloxacin oral solution in the 25 mg-per-mL strength. The drug is used to treat mild, moderate and severe bacterial infections in adults.

  • MinuteClinic enters clinical affiliation with Advocate Health Care, Advocate Physician Partners

    WOONSOCKET, R.I., and OAK BROOK, Ill. — CVS Caremark's retail-based clinic operator, MinuteClinic, has entered into a clinical affiliation with Advocate Health Care and Advocate Physician Partners to enhance the healthcare services provided to patients in communities throughout Chicagoland and central Illinois. The deal marks the largest clinical collaboration between a regional health system and MinuteClinic based on number of in-store clinic locations.

  • FDA: Teething OTC drugs associated with risk of methemoglobinemia

    SILVER SPRING, Md. — The Food and Drug Administration on Thursday posted a notification to healthcare professionals and patients that the agency continues to receive reports of methemoglobinemia, a serious and potentially fatal adverse effect, associated with benzocaine products, which are available as a spray, gel and liquids sold over the counter. Benzocaine products are used to relieve pain from a variety of conditions, such as teething, canker sores, and irritation of the mouth and gums.

  • Reese introduces Licide bed bug spray

    CLEVELAND — Reese Pharmaceutical has launched a water-based aerosol that is designed to kill bed bugs.

    The new Licide bed bug spray is designed to keep homes free of bed bugs for up to four weeks, the company said. The product is available in a 5-oz. size.

    Reese also will produce a private-label version of the Lucide bed bug spray, the company noted, and will distribute the products in retailers nationwide.

  • PL Developments to sell, distribute store-brand generic Zegerid OTC

    WESTBURY, N.Y. — PL Developments on Monday announced that it has acquired the exclusive rights to sell and distribute store-brand over-the-counter versions of omeprazole sodium bicarbonate capsules, the generic version of Merck’s Zegerid OTC.

    Par Pharmaceutical currently has approval for the prescription product and has filed for the OTC version. Upon FDA approval and upon favorable resolution of intellectual property litigation, PL Developments will begin marketing the new store-brand proton-pump inhibitor, the company stated.

  • Walgreens' executive client forum emphasizes employer health programs

    DEERFIELD, Ill. — Representatives from leading employers and payers met Monday to discuss the evolving role of employers in health care at the first Walgreens Employer Health and Wellness Executive Client Forum.

    The event features presentations from Walgreens executives on clinical outcomes data supporting the benefits of utilizing employer health programs beyond traditional services.

X
This ad will auto-close in 10 seconds